A 58-year-old woman with Parkinson disease presents with involuntary writhing movements of the limbs and trunk that worsen during the day and interfere with daily activities. Which motor complication is this, and what is the best clinical discriminator between this condition and dystonia associated with Parkinson disease?

Explanation

## Levodopa-Induced Dyskinesia vs. Parkinson Dystonia: Clinical Discrimination ### Definition and Timing **Key Point:** Levodopa-induced dyskinesia (LID) is a **dose-dependent involuntary movement disorder** that correlates with **peak plasma levodopa levels**, whereas Parkinson dystonia occurs during **off-medication periods** (early morning or end of dose interval). ### Comparative Table: LID vs. Dystonia in Parkinson Disease | Feature | Levodopa-Induced Dyskinesia (LID) | Parkinson Dystonia | |---------|-----------------------------------|-------------------| | **Timing** | Peak-dose dyskinesia (at max drug level) | Off-medication (early morning, end of dose) | | **Morphology** | Writhing, choreoathetoid, ballistic movements | Sustained muscle contractions, twisted postures | | **Body distribution** | Generalized (limbs, trunk, face) | Focal or segmental (foot, hand, neck) | | **Dose relationship** | Increases with higher levodopa doses | Improves with levodopa dose | | **Duration of PD** | Develops after 4–5 years of levodopa therapy | Can occur early, especially in young-onset PD | | **Management** | Reduce levodopa dose, add amantadine, DBS | Increase levodopa frequency, add anticholinergics | | **Pathophysiology** | Pulsatile dopaminergic stimulation → sensitization of striatal neurons | Inadequate dopaminergic tone in off-medication state | ### High-Yield Discriminator **High-Yield:** The **temporal relationship to medication** is the single best discriminator: - **LID** = **ON-medication** (peak-dose dyskinesia) or **biphasic dyskinesia** (at dose onset/offset) - **Dystonia** = **OFF-medication** (early morning, end of dose interval) ### Clinical Pearl **Clinical Pearl:** A patient who develops **writhing movements 1–2 hours after taking levodopa** (when drug levels peak) has **LID**. A patient with **foot inversion or hand cramping in the early morning before the first dose** has **off-medication dystonia**. ### Pathophysiology Insight **Mnemonic: PULSATILE** — The mechanism of LID: - **P**ulsatile dopaminergic stimulation (not continuous, as in healthy brain) - **U**nder-regulation of postsynaptic D1 and D2 receptors - **L**oss of buffering capacity in striatum (degeneration of nigrostriatal neurons) - **S**ensitization of medium spiny neurons to dopamine surges - **A**bnormal gene expression (ΔFosB, c-fos) - **T**ransduction cascades amplify dyskinesia risk - **I**nvoluntary movements emerge after 4–5 years - **L**evodopa dose and frequency are key risk factors - **E**arly intervention with lower doses, longer intervals, or dopamine agonists reduces risk ### Management Implications 1. **For LID:** Reduce levodopa dose, extend dosing intervals, add amantadine (NMDA antagonist), or consider DBS. 2. **For Dystonia:** Increase levodopa frequency, add anticholinergics (benztropine), or optimize dopaminergic therapy. [cite:Harrison 21e Ch 430; KD Tripathi 8e Ch 12]